Annual General Meeting Archive

Please see below information regarding Annual General Meetings of previous years.

The Annual General Meeting of Evotec SE was held on Monday, 10 June 2024, at 10.00 a.m. (CEST), at CinemaxX Hamburg-Dammtor, Room 1, Dammtordamm 1, 20354 Hamburg, Germany as an in-person event.

If you wish to view our Annual General Meeting archive you can do so here.

1. Presentation of the approved separate annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2023, as approved by the Supervisory Board, the management reports for Evotec SE and for the Group for the 2023 financial year, the report of the Supervisory Board for the 2023 financial year, and the explanatory report by the Management Board regarding this information pursuant to Sections 289a, 315a of the German Commercial Code (HGB) for the 2023 financial year
2. Resolution discharging the members of the Management Board of liability for the 2023 financial year
3. Resolution regarding formal approval of the actions of the members of the Supervisory Board for the 2023 financial year
4. Resolution regarding the appointment of the auditor for the separate financial statements and the consolidated financial statements for the 2024 financial year, and the appointment of the auditor for any review of additional financial information during the year
5. Resolution to approve the Remuneration Report 2023
6. Resolution concerning the creation of new authorised capital with the possibility to exclude subscription rights and amendment of Article 5 (5) of the Articles of Association (Authorised Capital 2024)
7. Resolution on amendments to the Articles of Association to adjust the terms of office, the requirements for the election of the Chairman of the Supervisory Board and his deputy and the remuneration of the Supervisory Board
   7.1. Terms of office of the Supervisory Board members
   7.2. Election of the Chairman of the Supervisory Board and his deputy
   7.3. Supervisory Board remuneration
8. Resolution concerning new elections to the Supervisory Board
   8.1. Prof. Dr. Iris Löw-Friedrich, Ratingen, Germany, Chief Medical Officer of UCB S.A. based in Brussels, Belgium
   8.2. Mr Roland Sackers, Cologne, Germany, Chief Financial Officer and Managing Director of QIAGEN N.V., Venlo, Netherlands
   8.3. Ms. Camilla Macapili Languille, Abu Dhabi, United Arab Emirates, Head of Life Sciences, Mubadala Investment Company, based in Abu Dhabi
   8.4. Dr Constanze Ulmer-Eilfort, Munich, Germany, partner at law firm Peters, Schönberger & Partner, based in Munich, Germany
   8.5. Dr Duncan McHale, London, UK, founder and director of Weatherden Ltd., based in London, UK.
   8.6. Mr. Wesley Wheeler, Chapel Hill, USA, Member of the Board of Directors at Envirotainer AB, headquartered in Sollentuna, Sweden
9. Resolution on the amendment of Section 15 Paragraph 4 Sentence 6 of the Articles of Association (record date)

Please find below the recording of the Management Speech at the Annual General Meeting 2024.

If you cannot view the recording above, please watch the Annual General Meeting here.

• Convening and Agenda of the Annual General Meeting, PDF
• Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212, PDF
• Annual Report 2023, PDF
• Annual financial statements 2023, PDF
• Corporate governance declaration for the 2023 financial year, PDF
• Information on agenda item 4 “Appointment of the auditor, the Group auditor for the 2024 financial year and the auditor for the review of additional interim financial information”, PDF
• Remuneration report 2023 on agenda item 5, PDF
• Additional Information regarding agenda item 5 (Approval of Remuneration Report)
• Report of the Management Board on agenda item 6, PDF
• Remuneration system for members of the Supervisory Board on agenda item 7.3, PDF
• CVs of the Supervisory Board candidates on agenda item 8, PDF
• Letter of the Chair of Supervisory Board to the Shareholders of Evotec
• Articles of Association Evotec SE, PDF
• Explanatory notes on the resolutionless item 1, PDF
• Explanation of shareholders' rights, PDF
• Total number of shares and voting rights at the time of convening the Annual General Meeting, PDF

• Power of attorney to the proxies of the Company, PDF
• Proxy to a third person, PDF
• Revocation of proxy, PDF

• Data Protection Information for Shareholders, PDF

There were no countermotions.

Confirmation of the vote count pursuant to section 129 (5) sentence 1 AktG

Pursuant to section 129 (5) sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month of the day of the Annual General Meeting as to whether and how his or her vote was counted. A request to this effect may be sent by e-mail to: evotec@linkmarketservices.eu 

 Hotline

Monday to Friday from 9 am to 5 pm by phone on +49 (0)89 8896906 610

Contact AGM Team

Evotec SE

Anja Ben Lekhal

Investor Relations Advisor

Manfred Eigen Campus

Essener Bogen 7

22419 Hamburg

T: +49 151 5187 1069

hauptversammlung@evotec.com 

Contact to the ADR Program

JPMorgan Chase & Co.

P.O. Box 64504

St. Paul, MN 55164-0504

USA

T: 800.990 1135 (from inside the USA)

T: +1.651.453 2128 (from outside the USA)

jpmorgan.adr@eq-us.com

The Annual General Meeting of Evotec SE was held on Tuesday, 20 June 2023, at 10:00 a.m. (CEST).

1. Presentation of the approved annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2022, as approved by the Supervisory Board, the management reports for Evotec SE and the Group for financial year 2022, the report of the Supervisory Board and the comments by the Management Board regarding this information pursuant to Sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch, HGB).
2. Resolution discharging the members of the Management Board of liability for financial year 2022.
3. Resolution regarding formal approval of the actions of the members of the Supervisory Board for financial year 2022.
4. Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for financial year 2023 and the appointment of the auditor for any review of additional financial information during the year.
5. Resolution cancelling the existing authorisation to issue convertible bonds and/or warrant-linked bonds and/or profit-linked bonds (or combinations of these instruments), to cancel the corresponding contingent capital and resolution to create a new authorisation to issue convertible bonds and/or warrant-linked bonds and/or profit-linked bonds (or combinations of these instruments), to create new contingent capital and to amend the Articles of Association.
6. Resolution to approve the Remuneration Report 2022.
7. Resolution amending the Company’s Articles of Association to enable virtual general meetings and other amendments in connection with virtual and hybrid general meetings.

Recoding live webcast Annual General Meeting 2023 (only Management Speech, without General Debate/Q&A)
_{20 June 2023, 10:00am CEST}

• Agenda and Convening of the Annual General Meeting, PDF
  
• Information Pursuant to Section 125 Para. 1 German Stock Corporation Act (AktG), PDF
• Explanations with Regard to Item 1 of the Agenda, PDF
• Report of the Management Board on Agenda Item 5, PDF
• Explanations on Shareholder Rights, PDF
• Total Number of Shares and Voting Rights at the Time of Convening the Annual General Meeting, PDF

• Annual Report 2022 Evotec SE, PDF
• Financial Statements 2022 Evotec SE, PDF
• Remuneration Report 2022 Evotec SE, PDF
• Articles of Association of Evotec, PDF
• Information on the Time of Service to Date of the Proposed Auditing Firm, PDF

• Power of Attorney the Company's Proxies, PDF
• Proxy to a Person of Your Choice, PDF
• Revocation of Proxy, PDF
• Data Protection Information for Shareholders, PDF

Confirmation of the counting of votes pursuant to section 129 (5) sentence 1 AktG:

Pursuant to § 129 para. 5 sentence 1 AktG, the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted.

A request to this effect may be sent by e-mail to evotec@better-orange.de.

Countermotions:

There were no countermotions.

Hotline:

Monday to Friday from 9 am to 5 pm by phone on +49 (0)89 8896906 610

Your AGM team

Evotec SE

Anja Ben Lekhal
Investor Relations Advisor
Manfred Eigen Campus
Essener Bogen 7
22419 Hamburg
T: +49 151 5187 1069
F: +49.(0)40.5 60 81-333
hauptversammlung@evotec.com

Contact to the ADR Program:

JPMorgan Chase & Co.
P.O. Box 64504
St. Paul, MN 55164-0504
USA
T: 800.990 1135 (from inside the USA)
T: +1.651.453 2128 (from outside the USA)
jpmorgan.adr@eq-us.com

The annual general meeting of Evotec SE was held on Wednesday, 22 June 2022, at 10.00 a.m. (CEST).

Agenda

1. Presentation of the approved annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2021, as approved by the Supervisory Board, the management reports for Evotec SE and the Group for financial year 2021, the report of the Supervisory Board and the comments by the Management Board regarding this information pursuant to Sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch, HGB).
2. Resolution discharging the members of the Management Board of liability for financial year 2021.
3. Resolution regarding formal approval of the actions of the members of the Supervisory Board for fiscal year 2021.
4. Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for financial year 2022 and the appointment of the auditor for any review of additional financial information during the year.
5. Resolution on re-election to the Supervisory Board
6. Resolution regarding the creation of new authorized capital with the possibility of precluding subscription rights and amendment of § 5 para 5 of the Articles of Association (Authorized Capital 2022).
7. Resolution on creating contingent capital for the issue of subscription rights to Management Board members of Evotec SE, members of management boards of affiliated companies in Germany and abroad and selected managers of Evotec SE and affiliated companies in Germany and abroad as part of a Share Performance Plan 2022 (SPP 2017), based on a resolution of authorization and amendments to the articles of association.
8. Resolution to approve the Remuneration Report 2021
9. Resolution to approve the revised remuneration system for the Management Board

Recording of the live webcast of the management speech at the Annual General Meeting 2022 (in German).
_{Wednesday, 22 June 2022, 10:00am CEST}

• Agenda and convening of the Annual General Meeting, PDF
• Information Pursuant to the Section 125 Para. 1 German Stock Corporation Act (AktG), PDF
• Explanations with Regard to Item 1 of the Agenda, PDF
• Curriculum Vitae Mrs Camilla Macapili Languille, PDF
• Report of the Management Board to the Annual General Meeting Concerning the Preclusion of the Subscription Right Regarding Item of the Agenda, PDF
• Remuneration Report 2021 of Evotec SE, PDF
• Description of the Remuneration System for Management Board Members and Supervisory Board Members (item 8 of the agenda), PDF
• Explanation on Shareholder Rights, PDF
• Total Number of Shares and Voting Rights at the Time of Convening the Annual General Meeting, PDF

• Annual Report 2021 Evotec SE, PDF
• Financial Statements 2021 Evotec SE, PDF
• Articles of Association of Evotec SE, PDF

• Power of Attorney to Company's Proxies, PDF
• Proxy to a Person of Your Choice, PDF
• Revocation of Proxy, PDF
• Data Protection Information for Shareholders, PDF

Confirmation of the counting of votes pursuant to section 129 (5) sentence 1 AktG:

Pursuant to § 129 para. 5 sentence 1 AktG, the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to: evotec@better-orange.de

Countermotions: There were no countermotions.

Hotline:

Monday to Friday (except public holidays) from 9 am to 5 pm

by phone: +49 (0)89 8896906 610

by e-mail: aktionaersportal2022@better-orange.de

Your AGM team

Evotec SE
Dr Werner Lanthaler
CEO

Anja Ben Lekhal
Investor Relations Associate
Manfred Eigen Campus
Essener Bogen 7
22419 Hamburg
T: +49.(0)40.5 60 81-210
F: +49.(0)40.5 60 81-333
hauptversammlung@evotec.com

Contact for holders of American Depositary Shares (ADSs):

JPMorgan Chase & Co.
P.O. Box 64504
St. Paul, MN 55164-0504
USA
T: (800).990.1135 (from inside the USA)
T: +1.651.453 2128 (from outside the USA)
jpmorgan.adr@eq-us.com

The annual general meeting of Evotec SE was held on Tuesday, 15 June 2021, at 10.00 a.m. (CEST).

The Company’s annual general meeting was held in virtual form without the physical presence of the shareholders or their representatives (with the exception of the voting representatives appointed by the Company).

The entire annual general meeting, including any answers to questions and voting, was live-streamed (audio and video) for shareholders and their representatives via the password-protected internet service.

Via the password-protected internet service, duly registered shareholders (or their proxies) were could, among other things, follow the virtual Annual General Meeting live-stream (in audio and video), exercise their voting rights by way of electronic postal voting in accordance with the procedures provided for this purpose, grant a power of attorney to a third party or a power of attorney with instructions to the Company's proxies, submit questions no later than 14 June 2021, 10.00 a.m. (CEST), or declare an objection to a resolution of the Annual General Meeting for the record during the Annual General Meeting.

The personal access data required for this purpose were sent to the shareholders or their proxies after registration for the Annual General Meeting. Persons other than the registered shareholders or their proxies could not follow the Annual General Meeting on the internet.

In case of later (sub-)authorization, the following applied: The use of the password-protected internet service by the proxy requires that the proxy receives the corresponding access data.

Agenda

1. Presentation of the approved annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2020, as approved by the Supervisory Board, the management reports for Evotec SE and the Group for financial year 2020, the report of the Supervisory Board and the comments by the Management Board regarding this information pursuant to Sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch, HGB)
2. Resolution discharging the members of the Management Board of liability for financial year 2020
3. Resolution discharging the members of the Supervisory Board of liability for financial year 2020
4. Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for financial year 2021 and the appointment of the auditor for any review of additional financial information during the year
5. Resolution on re-election to the Supervisory Board
6. Resolution regarding the cancellation of Authorised Capital 2017 and the creation of new authorised capital with the possibility of precluding subscription rights and amendment of § 5 para 5 of the Articles of Association (Authorised Capital 2021)
7. Resolution on the remuneration of Supervisory Board members
8. Resolution to approve the system of remuneration for members of the Management Board of Evotec SE

Recording of the live webcast of the annual general meeting (in German)
_{Tuesday, 15 June 2021, 10:00am CEST}

• New: Self-restriction Item 6 of the Agenda, PDF
• Agenda and Convening of the Annual General Meeting, PDF
• Information Pursuant to Section 125 Para. 1 German Stock Corporation Act (AktG), PDF
• Explanations With Regard to Item 1 of the Agenda, PDF
• Curriculum Vitae Dr Constanza Ulmer-Eilfort, PDF
• Report of the Management Board to the Annual General Meeting Concerning the Preclusion of the Subscription Right Regarding Item 6 of the Agenda, PDF
• Description of the Remuneration System for Management Board Members (Item 7 of the Agenda), PDF
• Description of the Remuneration System for Management Board Members (Item 8 of the Agenda), PDF
• Explanations on Shareholder Rights, PDF
• Total Number of Shares and Voting Rights at the Time on Convening the Annual General Meeting, PDF

• Annual Report 2020 Evotec SE, PDF
• Financial Statements 2020 Evotec SE, PDF
• Articles of Association of Evotec SE, PDF

• Power of Attorney to Company's Proxies, PDF
• Proxy to a Person of Your Choice, PDF
• Revocation of Proxy, PDF
• Data Protection Information for Shareholders, PDF

Hotline: Monday to Friday from 9 am to 5 pm by phone on +49 (0)89 211 297 78

Countermotions: There were no countermotions.

YOUR AGM TEAM

Evotec SE
Dr Werner Lanthaler
CEO

Anja Ben Lekhal
Investor Relations Associate
Manfred Eigen Campus
Essener Bogen 7
22419 Hamburg
T: +49.(0)40.5 60 81-210
F: +49.(0)40.5 60 81-333
hauptversammlung@evotec.com

CONTACT TO THE ADR PROGRAMME:

JPMorgan Chase & Co.
P.O. Box 64504
St. Paul, MN 55164-0504
USA
T: 800.990 1135 (from inside the USA)
T: +1.651.453 2128 (from outside the USA)
jpmorgan.adr@eq-us.com

The annual general meeting of Evotec SE was held on Tuesday, 16 June 2020, at 10.00 a.m. (CEST).

Agenda

1. Presentation of the approved annual financial statements and the consolidated financial statements of Evotec SE as of 31 December 2019, as approved by the Supervisory Board, the management reports for Evotec SE and the Group for financial year 2019, the report of the Supervisory Board and the comments by the Management Board regarding this information pursuant to Sections 289a para 1, 315a para 1 of the German Commercial Code (Handelsgesetzbuch, HGB)
2. Resolution discharging the members of the Management Board of liability for financial year 2019
3. Resolution discharging the members of the Supervisory Board of liability for financial year 2019
4. Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for financial year 2020 and the appointment of the auditor for any review of additional financial information during the year
5. Resolution on re-election to the Supervisory Board
6. Resolution on creating contingent capital for the issue of subscription rights to Management Board members of Evotec SE, members of management boards of affiliated companies in Germany and abroad and selected managers and employees of Evotec SE and affiliated companies in Germany and abroad as part of a Restricted Share Plan 2020 based on a resolution of authorization and amendments to the articles of association
7. Resolution on the revision of Article 15 para. 4 of the Articles of Association (attendance right)

Management Speech Annual General Meeting 2020 (in German)
_{Recording of the Management Speech at the Annual General Meeting, 16 June 2020}

The Annual General Meeting of Evotec SE took place on Wednesday, 19 June 2019, at 10.00 am (CEST), at the business premises of Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg.

Covering the introduction by Prof. Dr Wolfgang Plischke, the Chair of the meeting, and the speech given by Dr Werner Lanthaler, Chief Executive Officer of Evotec. (In German only)

The Annual General Meeting of Evotec AG took place on Wednesday, 20 June 2018, at 10.00 am (CEST), at the business premises of Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg.

The company will provide a webcast covering the introduction by Prof. Dr Wolfgang Plischke, the Chair of the meeting, and the speech given by Dr Werner Lanthaler, Chief Executive Officer of Evotec. (In German only.)

The Annual General Meeting of Evotec AG took place on Wednesday, 14 June 2017, at 10.00 am (CEST), at the Sofitel Hamburg Alter Wall, Alter Wall 40, D-20457 Hamburg.

Covering the introduction by Prof. Dr Wolfgang Plischke, the chair of the meeting, and the speech given by Dr Werner Lanthaler, Chief Executive Officer of Evotec.
_{Webcast in German only.}

The Annual General Meeting of Evotec AG took place on Tuesday, 14 June 2016, at 10.00 am (CEST), at the EMPORIO TOWER, Panoramadeck, Dammtorwall 15, D-20355 Hamburg.

Covering the introduction by Prof. Dr Wolfgang Pischke, the chair of the meeting, and the speech given by Dr Werner Lanthaler, Chief Executive Officer of Evotec.
_{Webcast in German only.}